• Bifidobacterium, FMT, and PET Imaging in Chronic HE

  2026-08-07

  This 2025 European Journal of Neuroscience study used [18F]PBR146 micro-PET/CT to compare Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy. Although global brain tracer uptake, behavior, and measured cytokines did not differ significantly, regional imaging and microbiome profiles suggested that Bifidobacterium may attenuate neuroinflammation more effectively than FMT in this model.

• ZIF8 Nanotheranostic Platform for Targeted TNBC Therapy

  2026-08-07

  Li et al. developed a folic acid-PEG-functionalized ZIF8 nanoplatform co-delivering ciprofloxacin for ultrasound-guided, synergistic treatment of triple-negative breast cancer. This multifunctional system integrates sonodynamic therapy, targeted chemotherapy, and immune activation, offering a promising strategy for precise cancer theranostics.

• Calcitriol in Bone and Immune Modulation: Protocols & Innova

  2026-08-06

  Calcitriol (1,25-dihydroxy vitamin D3) from APExBIO stands out for precise control in bone homeostasis and immune modulation research. Discover advanced workflows, troubleshooting strategies, and actionable insights for leveraging Calcitriol in cell-based assays targeting differentiation, inflammation, and signaling pathways.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-08-06

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses unwanted proteolytic degradation during protein extraction, preserving protein integrity for downstream analyses like Western blotting, co-immunoprecipitation (Co-IP), and kinase assays. Its EDTA-free formulation is particularly suited to workflows sensitive to divalent cations, but it is not appropriate for protocols requiring metalloprotease inhibition or those incompatible with DMSO.

• Laminin (925-933): Practical Guide for Cell Adhesion Assays

  2026-08-05

  Laminin (925-933) provides a defined, receptor-specific peptide tool for dissecting cell adhesion and migration mechanisms in vitro. It allows researchers to quantitatively modulate cell attachment and chemotaxis in controlled basement membrane protein research workflows. This product should not be used for diagnostic or therapeutic applications, nor as a substitute for full-length laminin in settings requiring broad multivalent matrix interactions.

• (R)-MG132 in Cancer Metabolism: Beyond the Negative Control

  2026-08-05

  (R)-MG132 serves as a stereochemically precise MG-132 enantiomer with unique advantages for dissecting proteasome-dependent mechanisms in cancer metabolism research. This article explores its scientific rationale, practical deployment in advanced assays, and critical insights gained from recent studies on metabolic rewiring in cervical cancer.

• Reelin–SFK Pathway Essential for Ketamine Antidepressant Res

  2026-08-04

  This study identifies synaptic Reelin signaling—specifically via Apoer2 and Src family kinases (SFKs)—as a critical determinant for ketamine-induced behavioral and synaptic plasticity effects. Disruption of this pathway impairs both baseline NMDA receptor function and the rapid antidepressant effects of ketamine, offering mechanistic insight into nonresponse in treatment-resistant depression.

• LGK-974 (PORCN Inhibitor): Translational Value in Wnt Pathwa

  2026-08-04

  Explore the unique mechanistic and translational potential of LGK-974, a potent PORCN inhibitor, in targeting Wnt signaling beyond oncology—featuring new insights from sclerosteosis models and practical guidance for experimental design.

• Co-Targeting BRD4 and RAC1 Disrupts Breast Cancer Stemness

  2026-08-03

  This study demonstrates that simultaneous inhibition of BET bromodomain BRD4 and RAC1 suppresses breast cancer growth and stemness by disrupting the c-MYC/G9a/FTH1 axis and downregulating HDAC1. The findings highlight the therapeutic potential of epigenetic and signaling co-targeting strategies in diverse molecular subtypes of breast cancer.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-08-03

  The reference study introduces a novel patient-derived gastric cancer assembloid system that integrates matched tumor organoids with autologous stromal cell subpopulations. This approach advances preclinical modeling by recapitulating tumor microenvironment complexity and enabling personalized drug response evaluation, with significant implications for understanding resistance mechanisms and optimizing targeted therapy.

• Linoleic Acid (C18:2(9Z,12Z)): Technical Guide for Lab Assay

  2026-08-02

  Linoleic Acid (SKU C3108) is a defined omega-6 fatty acid for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in cell and erythrocyte assays. It is not suitable for aqueous protocols or long-term solution storage, but is optimal for workflows requiring precise fatty acid supplementation and controlled oxidative conditions.

• Spiroplasma eriocheiris Entry: Clathrin-Mediated and Macropi

  2026-08-01

  This study provides the first mechanistic demonstration that Spiroplasma eriocheiris invades Drosophila S2 cells via clathrin-mediated endocytosis and macropinocytosis. These findings clarify key cellular entry routes for this pathogen in invertebrate hosts, informing future research on host-pathogen interactions and intracellular infection models.

• Strategic Use of Ionomycin Calcium Salt in Translational Onc

  2026-07-31

  Explore how Ionomycin calcium salt, a leading calcium ionophore, empowers translational researchers to dissect and modulate the STIM1-Ca2+ signaling axis in cancer progression. This article bridges mechanistic insight and practical guidance, contextualizing new findings on metastasis and apoptosis, and providing a blueprint for experimental design in advanced oncology research.

• MMP-2/9 Inhibition Preserves BBB and Cognition in Arsenic-Tr

  2026-07-31

  This study reveals that arsenic-induced cognitive impairment in male mice is driven by blood-brain barrier (BBB) disruption and neuronal apoptosis mediated through MMP-2 and MMP-9. Pharmacological inhibition of these matrix metalloproteinases with doxycycline hyclate preserves BBB integrity and neuronal viability, highlighting new mechanistic insight and therapeutic potential in arsenic neurotoxicity.

• Berbamine Hydrochloride: Advanced NF-κB Activity Inhibitor W

  2026-07-30

  Berbamine hydrochloride empowers cancer researchers to dissect NF-κB signaling and ferroptosis resistance with quantitative precision. This guide delivers stepwise protocols, addresses common troubleshooting pitfalls, and translates recent mechanistic breakthroughs into practical lab strategies.

457 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page